
I-Mab IMAB
Quartalsbericht 2025-Q4
hinzugefügt 11.04.2026
I-Mab Finanzkreislauf 2011-2026 | IMAB
Finanzkreislauf Jährlich I-Mab
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | -1.97 K | 15.5 | 4.65 | - | - | - | - | - | - | - | - |
Alle Zahlen in CNY-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 15.5 | -1.97 K | -649 |
Finanzkreislauf anderer Aktien in der Pharmaeinzelhändler
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
BeiGene, Ltd.
BGNE
|
52.6 | - | 0.49 % | $ 251 B | ||
|
bluebird bio
BLUE
|
-54.4 | - | - | $ 546 M | ||
|
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
205 | $ 21.38 | 0.09 % | $ 999 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Advaxis
ADXS
|
-143 K | - | -9.65 % | $ 45.9 M | ||
|
Clearside Biomedical
CLSD
|
-1.67 K | - | - | $ 25.3 M | ||
|
Aeterna Zentaris
AEZS
|
-34.3 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
Akebia Therapeutics
AKBA
|
42 | $ 1.56 | 6.12 % | $ 401 M | ||
|
Aquestive Therapeutics
AQST
|
-172 | $ 4.15 | -0.95 % | $ 444 M | ||
|
Arcutis Biotherapeutics
ARQT
|
158 | $ 25.09 | 4.02 % | $ 3.19 B | ||
|
Chimerix
CMRX
|
588 | - | - | $ 756 M | ||
|
AIkido Pharma
AIKI
|
-1.92 | - | 1.93 % | $ 17.4 M | ||
|
Celldex Therapeutics
CLDX
|
-3.74 K | $ 33.33 | 2.27 % | $ 2.21 B | ||
|
Autolus Therapeutics plc
AUTL
|
119 | $ 1.48 | 0.68 % | $ 394 M | ||
|
Cidara Therapeutics
CDTX
|
2.26 K | - | - | $ 1.41 B | ||
|
Evogene Ltd.
EVGN
|
-32.5 | $ 0.82 | 0.02 % | $ 27.9 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.15 K | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
-58 | - | - | $ 96.9 B | ||
|
CTI BioPharma Corp.
CTIC
|
-216 | - | - | $ 1.2 B |